Abstract
Monitoring trace circulating tumor cells (CTCs) in whole blood is important for early diagnosis and treatment of cancers. Whereas, it remains a major difficulty for detecting CTCs because of their extremely low contents in blood. Herein, by coupling biobarcode amplification method with sequence-responsive and enzyme-embedded DNA nanocapsules, we report a highly sensitive, label-free and specific electrochemical sensing assay to detect CTCs in blood. The target CTCs are selectively isolated from sample solutions by aptamer-conjugated magnetic beads and biobarcode DNA-functionalized polystyrene beads. Subsequent release of the biobarcode DNA can trigger the liberation of lots of enzymes from the nanocapsules, further leading to drastically enhanced catalytic current on the sensor electrode for detecting CTCs at the detection limit of 8 cell mL−1 in a non-label approach. Moreover, whole blood-spiked target CTCs can also be detected by the developed strategy, offering it the great promise for the monitoring of different rare CTCs in complex samples for various biomedical applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
